The BMJ requires data sharing on request for all trials

How we expect researchers to make all their data available

clinical-trial-capsules
From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials,
not just those that test drugs or devices. Image by Esther Dyson.

The movement to make data from clinical trials widely accessible has achieved enormous success, and it is now time for medical journals to play their part. From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials, not just those that test drugs or devices.

The BMJ’s Elizabeth Loder explains what this means for authors, and how we expect researchers to make their data available.

Press Play > to listen to the recording.

Sources and more information

Our SoundCloud Playlists

Health apps benefits and disadvantages for healthy people

Can healthy people benefit from health apps?

cell-phone-wth-apps
Some apps have the potential to encourage healthier habits and are accessible to most people, writes Iltifat Husain, but Des Spence notes the lack of any evidence of effectiveness and the potential for encouraging unnecessary anxiety.

What is the harm in health apps – none, right? And surely they can only be good at enhancing healthy behaviors? Or:

  • are there too many apps of too little value?
  • are there lots of potential for otherwise healthy people to get unhealthily worried – obsessed even – about their normal health?.

Press Play > to listen to the recording.

Sources and more information

  • Can healthy people benefit from health apps?, BMJ 2015;350:h1887, 14 April 2015.
  • What is the point of health apps when we are healthy?, medicalnewstoday, Wednesday 15 April 2015.
  • Report Questions Whether Health Apps Benefit Healthy People, nytimes, APRIL 14, 2015.
Our SoundCloud Playlists

Social egg freezing: risk, benefits and other considerations

Listen to Angel Petropanagos interview

egg on image image
Family physicians have an important role in advising women about the benefits and risks of egg freezing, argues an analysis in the Canadian Medical Association Journal.

Doctors are being warned not to encourage young women to freeze their eggs as a way to avoid “future regret,” says a just-published article in the Canadian Medical Association Journal that argues egg freezing risks perpetuating expectations that being a mother is central to being a woman.
Press Play > to listen to the recording.

Sources and more information

  • Social egg freezing: risk, benefits and other considerations, cmaj, April 13, 2015.
  • Family doctors important in advising young women on egg freezing for future fertility, eurekalert, 13-APR-2015.
  • Doctors warned not to encourage young women to freeze their eggs in new medical journal article, nationalpost, April 14, 2015.
  • Egg freezing not a fertility panacea, Metro Canada, April 14, 2015.
Our SoundCloud Playlists

The FDA and Medical Fraud missing from Public Record

Press Play > to listen to the recording

Science-Friday banner image
Faked X-rays, fabricated data, unreported amputations… those are just a few examples of the medical misconduct discovered during Food and Drug Administration inspections. Science Friday interviews Charles Seife.

In his recent investigation about the FDA, fraud and misconduct in scientific studies of medicine, Charles Seife – Journalist, author, NYU professor – and his students revealed that the FDA routinely fails to report evidence of fraud or misconduct when it inspects the way researchers conduct clinical trials, leaving the public unaware of which research is credible and which is not.
Press Play > to listen to the recording.

Sources and more information

  • Are Your Medications Safe?, slate, Feb. 9 2015.
  • Research Misconduct Identified by the US Food and Drug AdministrationOut of Sight, Out of Mind, Out of the Peer-Reviewed Literature, JAMA Intern Med. Published online, doi:10.1001/jamainternmed.2014.7774, February 09, 2015.
  • The FDA doesn’t tell you when it finds scientific fraud, theverge, February 9, 2015.
  • FDA fails to report fraud in clinical trials – study, Reuters, February 10, 2015.
  • Medical Fraud Missing From Public Record, sciencefriday, FEB. 13, 2015.
Our SoundCloud Playlists

France Procès Distilbène: une Sarthoise dénonce UCB Pharma

Carnet de Santé sur France Inter

10 janvier 2014 – Interview de Sylvie Le Cossec

La vie de Sylvie a été ravagée par le Distilbène, cette hormone de synthèse prescrite à sa mère et supposée éviter les fausses couches.

Deux grossesses pathologiques, un fils polyhandicapé à la vie dévastée, une carrière internationale stoppée, une vie de couple bouleversée, un cancer de l’utérus, un quotidien difficile à gérer… Sylvie publie son livre “Distilbène, Mon Fils n’aura Jamais son Bac” et dénonce le laboratoire UCB Pharma.

Le Distilbène DES, en savoir plus
Listes d’enregistrements sur SoundCloud

Medicine’s Missing Half

How withholding clinical trials degrades the evidence base

Science & the City interviews Dr Ben Goldacre – author of Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients – who discusses the pervasive bias in reporting clinical trials of medications.

Dr Ben Goldacre calls for all trials to be registered and for all trial results to be reported. Otherwise, he says, doctors, researchers, and patients are prevented from making discerning decisions about treatments and the field of evidence-based medicine is pointlessly hobbled.

More information

Our SoundCloud Playlists

Breast Cancer: Patti Neighmond reports about DES Daughters

DES Daughters and their Cancer Risk

Award-winning journalist Patti Neighmond is NPR’s health policy correspondent. Her reports air regularly on NPR newsmagazines All Things Considered, Morning Edition and Weekend Edition.

Patti reported about DES on 08 August 2006, following a “new” study showing that daughters of women who took the pregnancy drug DES, a synthetic estrogen, have a higher risk of developing breast cancer after age 50. Click here to read the story.

DES and Breast Cancer

More DES DiEthylStilbestrol Resources

Science Weekly @AlokJha @GuardianScience Interview: Dr @BenGoldacre exposes Bad Pharma #SoundCloud

Alok Jha, Science correspondent at the Guardian and BBC TV presenter, speaks with Campaigner, Writer, Dr Ben Goldacre about his investigation into the pharmaceutical industry and his book Bad Pharma.

More information

Find out about the DES Drug tragedy

  • All our posts tagged DES and DES-exposed
  • Diethylstilbestrol, Journal of a DES Daughter logo website, stay updated with Like Journal of a DES Daughter on Facebook , Circle Journal of a DES Daughter on Google Plus , Follow @des_journal
  • Our DES video playlist on DES Daughter Network channel DES Diethylstilboestrol's channel on YouTube
  • See DES images on Flickr DES Diethylstilbestrol's photostream on Flickr and Pinterest Follow DES Daughter on Pinterest

Extended Interview with Dr Ben Goldacre on SoundCloud

Guardian Science Weekly

Alok Jha, Science correspondent at the Guardian and BBC TV presenter, speaks at length with Campaigner, Writer, Dr Ben Goldacre about his investigation into the pharmaceuticals industry and his book Bad Pharma.

More information

Find out about the DES Drug tragedy

Have you heard “The Journey of a DES Daughter”?

Your @DES_Journal Interview by @TheOrganicView is on @SoundCloud

Recorded radio interview by The Organic View, with host, June Stoyer joined by your DES Daughter Domino talking about her journey.

Related posts

More DES DiEthylStilbestrol Resources